IMU and UK Biobank to generate the world’s most detailed, large-scale picture of the human immune system for advancing research into health and disease

IMU Biosciences announced a collaboration with UK Biobank to generate large-scale immune profiling data from 80,000 blood samples, with an ambition to expand across the full 500,000-participant cohort. Waters Corporation's flow cytometry and multi-omic instrumentation will be used in the project, extending the strategic partnership between Waters and IMU announced in June, while Ultima Genomics' UG200 platform produces sequencing readouts. IMU also received a £1.57 million UK Sovereign AI grant for the project.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.